Abstract
INTRODUCTION
Gastric cancer is one of the most common causes of malignancy-related death worldwide. In China, the annual average mortality rate of gastric carcinoma is as high as 16 per 100 thousand [1] . Environmental factors, diet that is high in salts and low in fresh fruit and vegetables are regarded as the risk of stomach cancer [2] [3] [4] [5] [6] . Although plenty of advances have been made in the gastrointestinal medicine, the inability to diagnose early and treat effectively of the gastric cancer remains an unsolved problem for clinicians [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] . Chemoprevention and chemotherapy including the use of natural products, synthetic compounds or dietary substances are promising ways to stop or reverse the process of carcinogenesis [24] . Large number of minor dietary components has been found to inhibit carcinogenesis at various stages [25] . Tributyrin is a neutral short-chain fatty acid triglyceride existed in some spice plants at low levels in nature [26] , and has been approved as a food additive in the United States [27] . Tributyrin is also a pro-drug of natural butyrate synthesized by the bacterial fermentation of various complex carbohydrates unabsorbed in the digestive tract [28] and has been reported bearing anti-tumor effect on neoplastic cells [27, 29, 30] as well as inhibiting proliferation and stimulating differentiation in multiple cancer cell lines. Most importantly, tributyrin is more lipophilic compared with the butyrate and can be metabolized by the intracellular lipases, progressively releasing therapeutically effective butyrate directly in the cell [26, 31] . However, the underlying mechanisms of tributyrin against different types of tumor remain to be understood and so far, the effect of tributyrin on gastric cancer cells has not been reported yet.
In this study, we are trying to evaluate the ability of tributyrin to inhibit cell proliferation, arrest DNA synthesis and induce apoptosis in human gastric cancer SGC-7901 cells and go further into some apoptosis-related events in these processes. 
MATERIALS AND METHODS

Cell lines and reagents
Assessment of cell proliferation
MTT assay was conducted to determine the cell proliferation. SGC-7901 cells were seeded in a 96-well plate (1×10 4 ·well -1 ) as described previously [32] . In brief, after 24 h incubation cells were treated with tributyrin for three days and untreated cells served as a control. Prior to the determination, 5 µL of the 2. 
Transmission electron microscopy
The cultured cells treated with 2 mmol·L -1 tributyrin for 48 h were trypsinized and harvested, respectively. Subsequently the cells were immersed with Epon 821, embedded in capsules and converged at 60 for 72 h, then they were prepared into ultrathin section (60 nm) and stained with uranyl acetate and lead citrate. Cell ultrastructure was examined by transmission electron microscopy.
Morphological change of apoptosis
The morphological changes of cell apoptosis were determined under fluorescence microscope. Briefly, the experimental cells were pelleted and fixed in 200 ml·L -1 ethanol/phosphatebuffered saline (PBS), stained with 5 mg·L -1 Hoechst-33258 for 10min at room temperature, then visualized under fluorescence microscope.
TUNEL assay
Apoptosis of SGC-7901 cells was analyzed by using in situ cell death detection kit. The method is essentially based on the terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) technique. In brief, after cells were treated with or without tributyrin for the indicated time, they were fixed overnight in 100 g·L -1 formaldehyde, then treated with proteinase K and H 2 O 2 , labeled with fluorescein dUTP in a humid box at 37 for 1 h and visualized under fluorescence microscope. The cells without addition of TdT enzyme were used as negative control.
Flow cytometry
After harvested, the experimental cells were washed with PBS twice and fixed with 700 mL·L -1 ethanol at 4 overnight. The fixed cells were washed twice with PBS and stained with 800 µL propidium iodide and 200 µL deoxyribonulcease-free ribonuclease A in PBS. The fluorescence density of propidium iodide-stained nuclei was determined by flow cytometry.
Western blot analysis
The experimental cells were lysed in lysis buffer [25 mmol·L -1 HEPES, 1.5 % Triton X-100, 1 % sodium deoxycholate, 0.1 % SDS, 0.5 mol·L -1 NaCl, 5 mmol·L -1 EDTA, 50 mmol·L -1 NaF, 0.1 mmol·L -1 sodium vanadate, 1 mmol·L -1 phenylmethylsulfonyl fluoride (PMSF), and 0.1 g·L -1 leupeptin (pH7.8)] at 4 with sonication. The lysates were centrifuged at 15 000 g for 15 min at 4 and the proteins were separated on SDS-PAGE, transferred to nitrocellulose filter and incubated with antibodies against Bcl-2, Bax, PARP, and Actin, respectively. Then the membrane was incubated with peroxidase-conjugated secondary antibodies. Detection was performed with enhanced chemiluminescence reagent.
Statistical analysis
Student's t test was used to assess statistical significance of differences. If P<0.05, the difference was considered statistically significant.
RESULTS
Inhibition of human gastric cancer SGC-7901 cell proliferation by tributyrin
The experimental SGC-7901 cells were treated with various concentrations of tributyrin for 1-3 days and the cell viability was determined as described above by MTT assay. As shown in Figure 1 , tributyrin could inhibit the growth of gastric cancer cells in a dose-and time-dependent manner. Cell growth was suppressed by 24.9 %, 36.6 %, 50.3 %, 60.6 %, 84.1 % and 91.3 % after 72 h treatment with tributyrin at 0.5, 1, 2, 5, 10 and 50 mmol·L -1 , respectively. It was noted that tributyrin at 50 mmol·L -1 had an inhibitory effect of more than 90 % on the tumor cell growth after 48-72 h treatment. The IC 50 value of tributyrin for SGC-7901 cell at 72 h was 2 mmol·L -1 . 
DNA synthesis arrest by tributyrin
Since the IC 50 value of tributyrin was 2 mmol·L -1 , the concentration was used for the following assay. Tributyrin inhibited the 
TUNEL assay
The TUNEL assay revealed that tributyrin could induce the apoptosis of SGC-7901 cells, while the negative control did not show any signs of fluorescence signals ( Figure 5 ).
Flow cytometry
Cell cycle analysis in SGC-7901 cells treated with tributyrin revealed that a sub-G1 apoptotic peak appeared ( Figure 6 ). The apoptosis rate in tributyrin-treated tumor cells was increased in a time-and dose-dependent manner. When treated with 2 mmol·L -1 tributyrin for 72 h, the experimental SGC-7901 cells showed a 41.5 % of apoptosis.
Differential expression of Bcl-2 and Bax protein and PARP cleavage in tributyrin-treated cells
After treated with indicated concentrations of tributyrin for 48 h, the expression of Bcl-2 protein was markedly decreased while that of Bax displayed an increased trend. PARP cleavage in the experimental cells appeared at 0.5 mmol·L -1 and was obvious at 2 mmol·L -1 of tributyrin treatment for 48 h (Figure 7 ). 
DISCUSSION
It has been reported tributyrin, a substance that naturally exists in some foods, was a potent agent against various malignancies, including colon and pancreas carcinomas, and that 1 mmol of tributyrin could result in an inhibitory effect comparable with 3 mmol of butyrate [32, 33] . The high lipophilic property and the long duration in blood made tributyrin a promising anti-tumor agent. However, the effects of tributyrin on gastric cancer cells have not been reported.
The present study demonstrated that tributyrin could inhibit the growth of human gastric cancer SGC-7901 cells in a doseand time-dependent manner, which might be caused by DNA synthesis arrest as shown in our experiment via preventing SGC-7901 cells from progressing into S-phase and ultimately blocking the cell proliferation. The inhibition of DNA synthesis was more than 90 % when SGC-7901 cells were treated with tributyrin at 2 mmol·L -1 for 48-72 h. Besides DNA synthesis arrest, the induced cell death was another major reason for the cell growth inhibition. Apoptosis, also called programmed cell death, is a natural process of cell suicide which plays a critical role in the development and homeostasis of metazoans [34, 35] . Our results that tributyrin could induce apoptosis in SGC-7901 cells revealed by the typical apoptotic alterations, including the morphological changes by electron microscopy, positive Hoechst-33258 staining, DNA fragmentation by TUNEL assay and apoptotic sub-G 1 peak by flow cytometry.
Apoptosis is a complex process regulated by a variety of factors [36] [37] [38] [39] . The members of the Bcl-2 family are important regulators in the apoptotic pathway with individual members that can suppress (eg Bcl-2, Bcl-xl) or promote (eg Bax, Bad) apoptosis. As an oncogene-derived protein, Bcl-2 confers a negative control in the pathway of cellular suicide machinery, whereas Bax, a Bcl-2-homologous protein, promotes cell death by competing with Bcl-2. Introduction of Bcl-2 into most eukaryotic cells has been reported to be able to protect the recipient cell from a wide variety of stress applications that lead to cell death [40, 41] . In the present study, we observed that the expression of Bcl-2 was reduced and that of Bax was upregulated, indicating the reduced ratio of Bcl-2/Bax might serve as a mechanism of SGC-7901 cells apoptosis induced by tributyrin. Its subsequent event might be the release of cytochrome c and caspase-3 activation. On the other hand, the cleavage of PARP, one of caspase-3 downstream target [42] , was also observed in the experimental SGC-7901 cells with the increase of tributyrin concentrations. However, PARP could also be cleaved through a parallel caspase-3 independent pathway. Therefore, the exact mechanism underlying the apoptosis of SGC-7901 cells needed to be further investigated.
In summary, we have demonstrated that tributyrin, an oral analogue of butyrate, could induce DNA synthesis arrest and apoptosis in human gastric cancer SGC-7901 cells in vitro. The effect was dose-and time-dependent. The apoptotic mechanism of the SGC-7901 cells induced by tributyrin was at least via the reduction of Bcl-2/Bax ratio. These data suggested that further evaluation of tributyrin, a promising antitumor agent, for the treatment gastric cancer was warranted.
